SCHEMBL23724874

SCHEMBL23724874

COC(=O)c1ccc(C=O)c(O)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.42
ERN1 O75460 4/20 0.42
ALDH1A1 P00352 1/20 0.41
TRIM24 O15164 1/20 0.39
TYR P14679 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
CYP1A2 P05177 2/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
RECQL P46063 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LCK P06239 1/20 0.38
PTGER4 P35408 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30836700 0.84 MAPK1 (0.43) MAPK1ERN1ALDH1A1CYP1A2MAPT
SCHEMBL30684974 0.83 NPSR1 (0.45) MAPK1ERN1ALDH1A1CYP1A2MAPT
SCHEMBL29110044 0.83 NPSR1 (0.45) MAPK1ERN1ALDH1A1CYP1A2MAPT
SCHEMBL30832432 0.81 MAPK1 (0.41) MAPK1ERN1ALDH1A1CYP1A2MAPT
SCHEMBL2558368 0.81 MAPK1 (0.41) MAPK1ERN1ALDH1A1CYP1A2MAPT
SCHEMBL23623990 0.81 MAPK1 (0.41) MAPK1ERN1ALDH1A1TRIM24TYR
SCHEMBL984339 0.81 MAPK1 (0.41) MAPK1ERN1ALDH1A1CYP1A2MAPT
SCHEMBL23554745 0.79 MAPK1 (0.39) MAPK1ERN1ALDH1A1CYP1A2MAPT
SCHEMBL31306903 0.77 MAPK1 (0.50) MAPK1ALDH1A1CYP1A2MAPTGAA
SCHEMBL908091 0.77 MAPK1 (0.50) MAPK1ALDH1A1CYP1A2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
CN-115413275-A Substituted 1,1 , -biphenyl compounds and methods of use thereof 爱彼特生物制药公司 2022-11-29 CN disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL MAPK1 3936/4885ERN1 3525/4885ALDH1A1 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.